ExploreWatchlistsPricing
  1. JP-listed companies
  2. Pharma Foods International Co., Ltd.
  3. Financials
  4. Total liabilities

Pharma Foods International Co., Ltd. (2929)

Market cap
¥19B
P/E ratio
12.6x
Pharmafoods develops functional ingredients and manufactures supplements, cosmetics, and drug treatments for food companies, pharmaceutical firms, and consumers through direct sales.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal liabilities (Million JPY)YoY (%)
Jul 31, 202521,101-15.55%
Jul 31, 202424,987-6.07%
Jul 31, 202326,601+10.45%
Jul 31, 202224,084+93.01%
Jul 31, 202112,478+140.49%
Jul 31, 20205,189+17.51%
Jul 31, 20194,415+82.44%
Jul 31, 20182,420+7.50%
Jul 31, 20172,251+130.72%
Jul 31, 2016976+241.38%
Jul 31, 2015286+17.52%
Jul 31, 2014243

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat